| Reagan-Udall Foundation

Read more about A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Read more about COVID-19 Transmission and Morbidity in Malawi

Read more about Prognostic Value of PtcO2 in Patients With COVID-19

Read more about Assessment of Functional Capacity in Long-COVID

Read more about RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

Read more about Retrospective Study of COVID-19 on Reproductive Function

Experts told our Robert King at POLITICO’s Next Generation of Health Care Therapies event Thursday that they’re excited about the potential for artificial intelligence to help develop and test gene therapies to treat rare diseases.

Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Risk of COVID_19

Hydrogen-Oxygen Generator With Nebulizer for Adjuvant Treatment of COVID-19 Positive Patients

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

COVID-19 Transmission and Morbidity in Malawi

Prognostic Value of PtcO2 in Patients With COVID-19

Assessment of Functional Capacity in Long-COVID

RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

Retrospective Study of COVID-19 on Reproductive Function

Gene Therapies: Hopes, Hurdles, and AI - POLITICO

Subscribe for updates from the Reagan-Udall Foundation for the FDA